Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)

forecasted

The NHLBI, along with NIAID, NIA, and NEI, intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for the Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) Program. The overall goal of the StARR program is to provide resident clinicians in training with in-depth research experiences early in their careers, in order to recruit, retain and accelerate independence of a pool of clinician-investigators with both clinical and research experience necessary to perform basic, clinical and/or translational research. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This NOFO will utilize the R38 activity code. Investigators with expertise and insights into this area are encouraged to begin to consider applying for this NOFO.